Lucy Breakwell1, Tara M Vogt2, Debbie Fleming3, Mary Ferris4, Elizabeth Briere5, Amanda Cohn2, Jennifer L Liang5. 1. Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Epidemic Intelligence Service Program, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: xdc3@cdc.gov. 2. Office of the Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. Division of Student Affairs, University of California Santa Barbara, Santa Barbara, California. 4. UCSB Student Health, University of California Santa Barbara, Santa Barbara, California. 5. Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
PURPOSE: During March-November 2013, five cases of serogroup B meningococcal disease occurred among University A undergraduates. The Centers for Disease Control and Prevention used the unlicensed MenB-4C (Bexsero, Novartis Vaccines), a serogroup B meningococcal vaccine, to control the outbreak. All undergraduates (n = 19,257) were offered two doses; 51% of undergraduates received ≥1 dose of MenB-4C. We conducted a knowledge, attitudes, and practice survey to understand which factors and sources of information impacted their decision on whether or not to receive vaccine. METHODS: An anonymous online survey was sent to University A undergraduates. The survey was implemented in June 2-30, 2014, and covered demographics, MenB-4C vaccination decision, and sources of information. Descriptive analyses were conducted. RESULTS: A total of 1,341 students completed the survey (response rate = 7.0%), of these 873 received ≥1 dose of MenB-4C. Among vaccinated respondents, the predominant reasons for receiving vaccine were knowledge of disease severity, parental recommendation, and believing that vaccination offered the best protection. Among unvaccinated respondents, the predominant reasons for not receiving vaccine were perception of low disease risk and concern over vaccine newness and safety. Respondents' top primary sources of information were e-mails from the university followed by their parents. CONCLUSIONS: Reasons behind respondents' decision to receive an unlicensed vaccine were similar to those reported for routinely recommended vaccines. Given the challenges around communicating the importance of receiving a vaccine that is not routinely recommended, respondents' primary sources of information, the university and their parents, could be targeted to improve coverage rates. Published by Elsevier Inc.
PURPOSE: During March-November 2013, five cases of serogroup B meningococcal disease occurred among University A undergraduates. The Centers for Disease Control and Prevention used the unlicensed MenB-4C (Bexsero, Novartis Vaccines), a serogroup B meningococcal vaccine, to control the outbreak. All undergraduates (n = 19,257) were offered two doses; 51% of undergraduates received ≥1 dose of MenB-4C. We conducted a knowledge, attitudes, and practice survey to understand which factors and sources of information impacted their decision on whether or not to receive vaccine. METHODS: An anonymous online survey was sent to University A undergraduates. The survey was implemented in June 2-30, 2014, and covered demographics, MenB-4C vaccination decision, and sources of information. Descriptive analyses were conducted. RESULTS: A total of 1,341 students completed the survey (response rate = 7.0%), of these 873 received ≥1 dose of MenB-4C. Among vaccinated respondents, the predominant reasons for receiving vaccine were knowledge of disease severity, parental recommendation, and believing that vaccination offered the best protection. Among unvaccinated respondents, the predominant reasons for not receiving vaccine were perception of low disease risk and concern over vaccine newness and safety. Respondents' top primary sources of information were e-mails from the university followed by their parents. CONCLUSIONS: Reasons behind respondents' decision to receive an unlicensed vaccine were similar to those reported for routinely recommended vaccines. Given the challenges around communicating the importance of receiving a vaccine that is not routinely recommended, respondents' primary sources of information, the university and their parents, could be targeted to improve coverage rates. Published by Elsevier Inc.
Entities:
Keywords:
KAP survey; Meningococcal disease; Serogroup B meningococcal vaccine; University students
Authors: Eric Richardson; Kathleen A Ryan; Robert M Lawrence; Christopher A Harle; Shivani M Desai; Melvin D Livingston; Amit Rawal; Stephanie A S Staras Journal: Hum Vaccin Immunother Date: 2021-06-02 Impact factor: 4.526
Authors: Heidi M Soeters; Lucy A McNamara; Amy E Blain; Melissa Whaley; Jessica R MacNeil; Susan Hariri; Sarah A Mbaeyi Journal: Emerg Infect Dis Date: 2019-03 Impact factor: 6.883
Authors: Marion de Vries; Liesbeth Claassen; Margreet J M Te Wierik; Danielle R M Timmermans; Aura Timen Journal: BMC Public Health Date: 2022-04-01 Impact factor: 3.295
Authors: Li Hao; Matthew T G Holden; Xin Wang; Lubomira Andrew; Sabine Wellnitz; Fang Hu; Melissa Whaley; Scott Sammons; Kristen Knipe; Mike Frace; Lucy A McNamara; Paul Liberator; Annaliesa S Anderson Journal: Microb Genom Date: 2018-04-04
Authors: Marion de Vries; Liesbeth Claassen; Margreet J M Te Wierik; Feray Coban; Albert Wong; Danielle R M Timmermans; Aura Timen Journal: Emerg Infect Dis Date: 2020-07 Impact factor: 6.883